Shares of PainReform Ltd. (NASDAQ:PRFX – Get Free Report) were up 0.7% on Monday . The stock traded as high as $1.44 and last traded at $1.40. Approximately 91,938 shares were traded during trading, a decline of 94% from the average daily volume of 1,460,699 shares. The stock had previously closed at $1.39.
PainReform Trading Up 0.7%
The firm has a market capitalization of $2.81 million, a P/E ratio of -0.01 and a beta of 0.56. The firm has a 50-day moving average of $1.76 and a two-hundred day moving average of $2.42.
About PainReform
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations.
See Also
- Five stocks we like better than PainReform
- What Does a Stock Split Mean?
- These 3 Undervalued Stocks Could Surge as Value Rotation Nears
- How to trade using analyst ratings
- Tilray Shares Blazing: What’s Behind the 55% Rally This Month?
- Where to Find Earnings Call Transcripts
- 3 Retail Stocks to Watch as Back-to-School Spending Ramps Up
Receive News & Ratings for PainReform Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PainReform and related companies with MarketBeat.com's FREE daily email newsletter.
